Dabigatran results similar to warfarin in diabetes with NVAF

Article

Patients with nonvalvular atrial fibrillation (NAVF) who also have diabetes experienced similar safety and efficacy with dabigatran relative to warfarin, in comparison without diabetes who have NVAF.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.